Previous studies have linked variation in the expression of DKK1 by synovial fibroblasts to rheumatic diseases associated with excessive bone formation, primarily AS [13,21] although abnormal expression of the osteocyte-specific protein (and Wnt signalling inhibitor) sclerostin has also been described [22]. This evidence concerns the gene SOST and rheumatic disorder.